Factors influencing influenza-vaccination in adults under immunosuppressive therapy for a systemic inflammatory disease

Med Mal Infect. 2009 Apr;39(4):247-51. doi: 10.1016/j.medmal.2009.01.009. Epub 2009 Mar 20.

Abstract

Objective: The aim of this study was to evaluate flu vaccination rates and influencing factors in patients with systemic inflammatory diseases.

Methods: All patients presenting with a systemic inflammatory disease and taking immunosuppressants, who were hospitalized or had consulted in our internal medicine department between January 2 and 31, 2006, were included in the study. The information concerning flu vaccination was collected with a standardized form.

Results: One hundred and thirty-seven patients (mean age 53.1+/-17.6years; 40 [29%] male patients) were included: 39 (28%) had received flu vaccination in 2005 including 14 (16.7%) of the 84 patients with no other indication for flu vaccination than IS-induced immunodepression and 25 (47.2%) of the 53 patients with other flu vaccination indication(s) (p<0.001). The most frequent reasons for non-vaccination were: absence of physician recommendation (58%), fear of adverse effects (35%) and concern on vaccine clinical effectiveness (5%). The vaccination rate was significantly higher (49%) among patients who remembered having received a voucher from the French National Health Insurance Agency versus 18% among those who did not (OR=4.2 [95%CI, 1.92-9.19] p<0.05). This correlation remained significant after adjustment for confounding factors in a logistic regression model.

Conclusion: Influenza-vaccination coverage is low in patients receiving immunosuppressive therapy for systemic inflammatory diseases. We have to increase the influenza-vaccination coverage in this population.

MeSH terms

  • Female
  • Humans
  • Immunosuppression Therapy*
  • Immunosuppressive Agents / therapeutic use
  • Inflammation / drug therapy
  • Influenza Vaccines*
  • Male
  • Middle Aged
  • Vaccination / statistics & numerical data*

Substances

  • Immunosuppressive Agents
  • Influenza Vaccines